Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

cT2a N0NxM0 Renal Tumor × Axitinib × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Renal Cell 20 Kidney Neoplasms 6 Neoplasms 5 Uterine Cervical Neoplasms 3 Neoplasm Metastasis 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Ovarian Neoplasms 2 Melanoma 2 Endometrial Neoplasms 2 Clear-cell metastatic renal cell carcinoma 2 Carcinoma, Non-Small-Cell Lung 2 cT2a N0NxM0 Renal Tumor 1 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Radiation Therapy 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphatic Metastasis 1 Lung Neoplasms 1 Kidney Diseases 1 Gastrointestinal Stromal Tumors 1 Fallopian Tube Neoplasms 1 Esophageal Neoplasms 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Cystadenocarcinoma, Serous 1 Colorectal Neoplasms 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02597322 2025-04-06

AXIPAN

Assistance Publique - Hôpitaux de Paris

Phase 2 Completed

cT2a N0NxM0 Renal Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡